• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Clarification of the pathogenesis of myeloproliferative neoplasms based on the identification of genetic factors in familial cases

Research Project

Project/Area Number 17H04211
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionJuntendo University

Principal Investigator

Komatsu Norio  順天堂大学, 医学部, 教授 (50186798)

Co-Investigator(Kenkyū-buntansha) 森下 総司  順天堂大学, 医学部, 助教 (10635866)
荒木 真理人  順天堂大学, 医学(系)研究科(研究院), 先任准教授 (80613843)
Project Period (FY) 2017-04-01 – 2020-03-31
Project Status Completed (Fiscal Year 2019)
Budget Amount *help
¥17,160,000 (Direct Cost: ¥13,200,000、Indirect Cost: ¥3,960,000)
Fiscal Year 2019: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2018: ¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2017: ¥9,490,000 (Direct Cost: ¥7,300,000、Indirect Cost: ¥2,190,000)
Keywords骨髄増殖性腫瘍 / iPS細胞 / JAK2V617F変異 / CRISPR/Cas9 / JAK2 / iPS / ゲノム編集 / 網羅的遺伝子解析 / 家族性骨髄増殖性腫瘍 / ドライバー遺伝子 / 骨髄線維症 / 急性白血病 / 遺伝子 / 癌 / 細胞 / ゲノム
Outline of Final Research Achievements

Philadelphia negative myeloproliferative neoplasms (MPN) are clonal disorders characterized by an overproduction of terminally differentiated hematopoietic cells. A majority of patients with MPN harbor JAK2V617F mutation, which is though as a driver gene mutation. Despite of several studies using mouse models and cell lines that link the JAK2V617F mutation and MPN, it was ambiguous whether JAK2V617F mutation alone was sufficient for the presentation of MPN phenotypes such as overproduction of terminally differentiated hematopoietic cells. In this study, we employed iPS cells derived from a healthy donor, introduced JAK2V617F mutation into these iPS cells, and demonstrated that the JAK2V617F alone was sufficient to induce MPN phenotypes in vitro.

Academic Significance and Societal Importance of the Research Achievements

健常人から作ったiPS細胞にJAK2V617F変異を導入したところ、骨髄増殖性腫瘍患者でみられる造血能の亢進を、iPS細胞でも観察することができ、このiPS細胞を用いてJAK2V617F遺伝子の役割を解析することに成功した。このことから、今後はこのiPS細胞を用いて、新たな治療法の開発や病態解明がすすめられることから、その学術的意義、社会的意義は大きいと考える。

Report

(4 results)
  • 2019 Annual Research Report   Final Research Report ( PDF )
  • 2018 Annual Research Report
  • 2017 Annual Research Report
  • Research Products

    (60 results)

All 2019 2018 2017

All Journal Article (15 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 15 results,  Open Access: 7 results) Presentation (35 results) (of which Int'l Joint Research: 6 results,  Invited: 2 results) Book (9 results) Patent(Industrial Property Rights) (1 results)

  • [Journal Article] Mutant calreticulin interacts with MPL in the secretion pathway for activation on the cell surface2019

    • Author(s)
      Masubuchi Nami、Araki Marito、Yang Yinjie、Hayashi Erina、Imai Misa、Edahiro Yoko、Hironaka Yumi、Mizukami Yoshihisa、Kihara Yoshihiko、Takei Hiraku、Nudejima Mai、Koike Masato、Ohsaka Akimichi、Komatsu Norio
    • Journal Title

      Leukemia

      Volume: 34 Issue: 2 Pages: 499-509

    • DOI

      10.1038/s41375-019-0564-z

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The role of calreticulin mutations in myeloproliferative neoplasms2019

    • Author(s)
      Araki Marito、Komatsu Norio
    • Journal Title

      International Journal of Hematology

      Volume: 111 Issue: 2 Pages: 200-205

    • DOI

      10.1007/s12185-019-02800-0

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Homomultimerization of mutant calreticulin is a prerequisite for MPL binding and activation2018

    • Author(s)
      Araki Marito、Yang Yinjie、Imai Misa、Mizukami Yoshihisa、Kihara Yoshihiko、Sunami Yoshitaka、Masubuchi Nami、Edahiro Yoko、Hironaka Yumi、Osaga Satoshi、Ohsaka Akimichi、Komatsu Norio
    • Journal Title

      Leukemia

      Volume: 33 Issue: 1 Pages: 122-131

    • DOI

      10.1038/s41375-018-0181-2

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Skewed megakaryopoiesis in human induced pluripotent stem cell-derived haematopoietic progenitor cells harbouring calreticulin mutations2018

    • Author(s)
      Hiraku Takei, Yoko Edahiro, Shuichi Mano, Nami Masubuchi, Yoshihsa Mizukami, Misa Imai, Soji Morishita, Kyohei Misawa, Tomonori Ochiai, Satoshi Tsuneda, Hiroshi Endo, Sou Nakamura, Koji Eto, Akimichi Ohsaka, Marito Araki, Norio Komatsu
    • Journal Title

      British Journal of Haematology

      Volume: 印刷中 Issue: 6 Pages: 791-802

    • DOI

      10.1111/bjh.15266

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The 2014 BCSH criteria and the 2016 WHO criteria for essential thrombocythemia: A comparison in a large-scale cohort.2018

    • Author(s)
      Ochiai T, Yasuda H, Araki M, Misawa K, Morishita S, Nudejima M, Hironaka Y, Shirane S, Edahiro Y, Gotoh A, Ohsaka A, Komatsu N.
    • Journal Title

      Eur J Haematol

      Volume: 印刷中 Issue: 6 Pages: 544-549

    • DOI

      10.1111/ejh.13041

    • Related Report
      2018 Annual Research Report 2017 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms.2018

    • Author(s)
      Misawa K, Yasuda H, Araki M, Ochiai T, Morishita S, Shirane S, Edahiro Y, Gotoh A, Ohsaka A, Komatsu N.
    • Journal Title

      Int J Hematol

      Volume: 印刷中 Issue: 6 Pages: 673-680

    • DOI

      10.1007/s12185-018-2421-7

    • Related Report
      2018 Annual Research Report 2017 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Multiple Placental Infarcts in a Pregnant Woman with Essential Thrombocythemia.2018

    • Author(s)
      Edahiro Y, Ando J, Suzuki T, Fukumura Y, Masuda A, Sakayori S, Takeda J, Maruyama Y, Makino S, Itakura A, Komatsu N.
    • Journal Title

      Internal Medicine.

      Volume: 57 Pages: 3647-3650

    • NAID

      130007531198

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Effect of ruxolitinib therapy on the quality-of-life of Japanese patients with myelofibrosis.2018

    • Author(s)
      Oritani K, Ohishi K, Okamoto S, Kirito K, Komatsu N, Tauchi T, Handa H, Saito S, Takenaka K, Shimoda K, Okada H, Amagasaki T, Wakase S, Shimozuma K, Akashi K.
    • Journal Title

      Curr Med Res Opin.

      Volume: 34 Pages: 531-537

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Evaluation of the dose and efficacy of ruxolitinib in Japanese patients with myelofibrosis.2018

    • Author(s)
      Kirito K, Okamoto S, Ohishi K, Tauchi T, Handa H, Saito S, Takenaka K, Shimoda K, Oritani K, Akashi K, Okada H, Amagasaki T, Suzuki K, Yonezu T, Komatsu N
    • Journal Title

      Int J Hematol

      Volume: 107(1) Issue: 1 Pages: 92-97

    • DOI

      10.1007/s12185-017-2332-z

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Somatic mutations of calreticulin in myeloproliferative neoplasms2017

    • Author(s)
      Imai Misa、Araki Marito、Komatsu Norio
    • Journal Title

      Int J Hematol

      Volume: 105 Issue: 6 Pages: 743-747

    • DOI

      10.1007/s12185-017-2246-9

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Novel molecular mechanism of cellular transformation by a mutant molecular chaperone in myeloproliferative neoplasms2017

    • Author(s)
      Araki Marito、Komatsu Norio
    • Journal Title

      Cancer Sci

      Volume: 108 Issue: 10 Pages: 1907-1912

    • DOI

      10.1111/cas.13327

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Hmga2 collaborates with JAK2 V617F in the development of myeloproliferative neoplasms2017

    • Author(s)
      Ueda K, Ikeda K, Ikezoe T, Harada-Shirado K, Ogawa K, Hashimoto Y, Sano T, Ohkawara H, Kimura S, Shichishima-Nakamura A, Nakamura Y, Shikama Y, Mori T, Mason PJ, Bessler M, Morishita S, Komatsu N, Shide K, Shimoda K, Koide S, Aoyama K, Oshima M, Iwama Aand Takeishi Y.
    • Journal Title

      Blood Advances

      Volume: 1 Issue: 15 Pages: 1001-1015

    • DOI

      10.1182/bloodadvances.2017004457

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] The 2016 WHO diagnostic criteria for polycythemia vera renders an accurate diagnosis to a broader range of patients including masked polycythemia vera: Comparison with the 2008 WHO diagnostic criteria.2017

    • Author(s)
      Misawa K, Yasuda H, Araki M, Ochiai T, Morishita S, Nudejima M, Hironaka Y, Shirane S, Edahiro Y, Gotoh A, Ohsaka A, Komatsu N.
    • Journal Title

      Am J Hematol

      Volume: 92 Issue: 7

    • DOI

      10.1002/ajh.24752

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis.2017

    • Author(s)
      Komatsu N, Kirito K, Shimoda K, Ishikawa T, Ohishi K, Ohyashiki K, Takahashi N, Okada H, Amagasaki T, Yonezu T, Akashi K.
    • Journal Title

      Int J Hematol.

      Volume: 105 Pages: 309-317

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey.2017

    • Author(s)
      Harrison CN, Koschmieder S, Foltz L, Guglielmelli P, Flindt T, Koehler M, Mathias J, Komatsu N, Boothroyd RN, Spierer A, Perez Ronco J, Taylor-Stokes G, Waller J, Mesa RA.
    • Journal Title

      Ann Hematol.

      Volume: 96 Issue: 10 Pages: 1653-1665

    • DOI

      10.1007/s00277-017-3082-y

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access
  • [Presentation] JAK2 V617Fのコピー数はサイトカイン受容体の活性化に重要である.2019

    • Author(s)
      北澤爽汰, 荒木真理人, 塩入香穂, 森下総司, 増渕菜弥, 馬場照美, 山本誠司, 堀内祥行, 今井美沙, 大坂顯通, 小松則夫.
    • Organizer
      第81回日本血液学会学術集会
    • Related Report
      2019 Annual Research Report
  • [Presentation] 抗TfR1抗体による真性多血症内因性赤芽球コロニーの形成阻害.2019

    • Author(s)
      木原慶彦, 増渕菜弥, 張黎臨, 荒木真理人, 小松則夫.
    • Organizer
      第81回日本血液学会学術集会
    • Related Report
      2019 Annual Research Report
  • [Presentation] 腫瘍随伴性血管炎を合併した真性多血症.2019

    • Author(s)
      福田泰隆, 枝廣陽子, 森下総司, 筒井深雪, 新田英昭, 安藤純, 荒木真理人, 小松則夫.
    • Organizer
      第81回日本血液学会学術集会
    • Related Report
      2019 Annual Research Report
  • [Presentation] JAK2アレルバーデンの高い患者は血小板コントロールが良好でもvWF活性低値のリスクが高い.2019

    • Author(s)
      飯塚和秀, 入山規良, 森下総司, 三浦勝浩, 飯塚芳一, 西崎祐史, 柳澤尚武, 安藤純, 内野慶人, 高橋宏通, 中川優, 濱田高志, 八田善弘, 中山智祥, 武井正美, 小松則夫.
    • Organizer
      第81回日本血液学会学術集会
    • Related Report
      2019 Annual Research Report
  • [Presentation] 心筋梗塞・脳梗塞患者におけるJAK2 V617F変異の頻度.2019

    • Author(s)
      筒井深雪, 森下総司, 西野隆, 枝廣陽子, 常田聡, 荒木真理人, 大坂顯通, 小松則夫.
    • Organizer
      第81回日本血液学会学術集会
    • Related Report
      2019 Annual Research Report
  • [Presentation] 非ドライバー変異と予後予測システムDIPSS/DIPSS-plus.2019

    • Author(s)
      森下総司, 落合友則, 三澤恭平, 大佐賀智, 稲野資明, 福田泰隆, 黒川安満, 枝廣陽子, 橳島麻衣, 緑川直子, 荒木真理人, 大坂顯通, 小松則夫.
    • Organizer
      第81回日本血液学会学術集会
    • Related Report
      2019 Annual Research Report
  • [Presentation] UT-7とともに歩んだ血液人生.2019

    • Author(s)
      小松則夫.
    • Organizer
      第81回日本血液学会学術集会
    • Related Report
      2019 Annual Research Report
    • Invited
  • [Presentation] 真性多血症患者由来iPS細胞におけるJAK2 V617F変異の修正.2019

    • Author(s)
      枝廣陽子, 劉暢, 荒木真理人, 橳島麻衣, 森下総司, 今井美沙, 増渕菜弥, 水上喜久, 眞野修一, 竹井拓, 大坂顯通, 小松則夫.
    • Organizer
      第81回日本血液学会学術集会
    • Related Report
      2019 Annual Research Report
  • [Presentation] The impact of allelic burden of JAK2V617F on human hematopoietic cell differentiation.2019

    • Author(s)
      枝廣陽子, 竹井拓, ChangLiu, 橳島麻衣, 森下総司, 大坂顯通, 荒木真理人, 小松則夫.
    • Organizer
      第29回日本サイトメトリー学会学術集会
    • Related Report
      2019 Annual Research Report
  • [Presentation] 真正トリプルネガティブ本態性血小板血症における臨床的・分子生物学的特異性.2019

    • Author(s)
      稲野資明, 荒木真理人, 森下総司, 落合友則, 三澤恭平, 福田泰隆, 緑川直子, 橳島麻衣, 伊藤雅文, 大佐賀智, 枝廣陽子, 今井美沙, 田口鉄平, 奥田真帆, 大坂顯通, 小松則夫.
    • Organizer
      第81回日本血液学会学術集会
    • Related Report
      2019 Annual Research Report
  • [Presentation] Mutations in epigenetic and splicing related genes among japanese overt and prefibrotic primary myelofibrosis using target sequencing.2019

    • Author(s)
      Morishita S, Ochiai T, Misawa K, Inano T, Fukuda Y, Kurokawa Y, Edahiro Y, Araki M, Ohsaka A, Komatsu N.
    • Organizer
      The 10th JSH INTERNATIONAL SYMPOSIUM
    • Related Report
      2019 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 骨髄増殖性腫瘍の最前線~本態性血小板血症を中心に.2019

    • Author(s)
      小松則夫.
    • Organizer
      輸血細胞治療学会九州支部会
    • Related Report
      2019 Annual Research Report
    • Invited
  • [Presentation] The Zygosity of JAK2V617F Determines the Disease Entities of Myeloproliferative Neoplasms By Modulating Erythropoiesis but Not Megakaryopoiesis.2018

    • Author(s)
      Takei H, Edahiro Y, Li L, Mizukami Y, Imai M, Morishita S, Ohsaka A, Araki M, Komatsu N.
    • Organizer
      ASH 60th Annual Meeting and Exposition
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Copy number of JAK2V617F modulates human hematopoietic cell differentiation.2018

    • Author(s)
      Edahiro Y, Mano S, Takei H, Li L, Morishita S, Gotoh A, Tsuneda S, Ohsaka A, Araki M, Komatsu N.
    • Organizer
      8th International Conference on Myeloproliferative Neoplasms
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Boarding on the secretary pathway is required for the oncogenic property of mutant calreticulin.2018

    • Author(s)
      Araki M, Masubuchi N, Hayashi E, Yang Y, Imai M, Kihara Y, Mizukami Y, Hironaka Y, Edahiro Y, Ohsaka A, Komatsu N.
    • Organizer
      23rd Congress of the European Hematology Association
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 受容体活性化において野生型JAK2は変異型JAK2を抑制しているようである.2018

    • Author(s)
      北澤爽汰, 荒木真理人, 森下総司, 楊印杰, 今井美沙, 大坂顕通, 小松則夫.
    • Organizer
      第80回日本血液学会学術集会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 細胞減少療法はPMF患者における腎機能の悪化を防止する.2018

    • Author(s)
      福田泰隆, 荒木真理人, 山本紘司, 森下総司, 稲野資明, 三澤恭平, 落合友則, 枝廣陽子, 今井美沙, 後藤明彦, 大坂顯通, 小松則夫.
    • Organizer
      第80回日本血液学会学術集会
    • Related Report
      2018 Annual Research Report
  • [Presentation] JAK2V617F変異アレル数はヒト血球分化を変化させる.2018

    • Author(s)
      竹井拓, 枝廣陽子, 李麗華, 水上喜久, 森下総司, 大坂顯通, 荒木真理人, 小松則夫.
    • Organizer
      第80回日本血液学会学術集会
    • Related Report
      2018 Annual Research Report
  • [Presentation] ターゲット遺伝子シーケンスパネルによる原発性骨髄線維症の遺伝子変異解析.2018

    • Author(s)
      森下総司, 落合友則, 三澤恭平, 稲野資明, 橳島麻衣, 大坂顕道, 小松則夫.
    • Organizer
      第80回日本血液学会学術集会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 変異型 CALRの多量体化は MPLとの結合と活性化に必須である.2018

    • Author(s)
      荒木真理人, 楊印杰, 今井美沙, 水上喜久, 木原慶彦, 角南義孝, 増渕菜弥, 枝廣陽子, 弘中由美, 大佐賀智, 大坂顯通, 小松則夫.
    • Organizer
      第80回日本血液学会学術集会
    • Related Report
      2018 Annual Research Report
  • [Presentation] トリプルネガティブ本態性血小板血症症例の臨床像と遺伝子変異.2018

    • Author(s)
      稲野資明, 荒木真理人, 福田泰隆, 森下総司, 落合友則, 三澤恭平, 伊藤雅文, 山本紘司, 楊印杰, 田口鉄平, 枝廣陽子, 今井美沙, 後藤明彦, 大坂顯通, 小松則夫.
    • Organizer
      第80回日本血液学会学術集会
    • Related Report
      2018 Annual Research Report
  • [Presentation] UT-7/EpoおよびK562に対するCRISPR/Cas9法を用いたCALRおよびJAK2V617F変異の導入.2018

    • Author(s)
      安田峻一郎, 青山慧, 渡邊大介, 荒木真理人, 小松則夫, 三浦修, 川又紀彦.
    • Organizer
      第80回日本血液学会学術集会
    • Related Report
      2018 Annual Research Report
  • [Presentation] Establishment of an in vitro model for the skewed megakaryopoiesis by calreticulin mutation in human cells.2017

    • Author(s)
      Takei H, Mano S, Masubuchi N, Mizukami Y, Morishita S, Imai M, Edahiro Y, Hironaka Y, Nudejima M, Tsuneda S, Endo H, Nakamura S, Eto K, Ohsaka A, Araki M, Komatsu N.
    • Organizer
      22nd Congress of the European Hematology Association
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Localization of Mutant Calreticulin in the Golgi Apparatus Is Required for Its Oncogenic Capacity.2017

    • Author(s)
      Masubuchi N, Araki M, Hayashi E, Yang Y, Imai M, Kihara Y, Mizukami Y, Hironaka Y, Takei H, Edahiro Y, Ohsaka A, Komatsu N.
    • Organizer
      59th Annual Meeting of the American Society of Hematology and Exposition
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 家族性骨髄増殖性腫瘍患者からの iPS細胞株の樹立.2017

    • Author(s)
      眞野修一, 竹井拓, 森下総司, 水上喜久, 増渕菜弥, 弘中由美, 橳島麻衣, 常田聡, 大坂顯通, 荒木真理人, 小松則夫.
    • Organizer
      第79回日本血液学会学術集会
    • Related Report
      2017 Annual Research Report
  • [Presentation] 骨髄増殖性腫瘍に見出される変異型 CALR 蛋白質の細胞内局在.2017

    • Author(s)
      林英里奈, 荒木真理人, 増渕菜弥, 水上喜久, 楊印杰, 今井美沙, 弘中由美, 竹井拓, 木原慶彦, 枝廣陽子, 大坂顯通, 小松則夫.
    • Organizer
      第79回日本血液学会学術集会
    • Related Report
      2017 Annual Research Report
  • [Presentation] Clinical Performance Study of a novel JAK2V617F mutation quantitative kits for patients with Ph-MPN.2017

    • Author(s)
      野口雅章, 小松則夫, 小池道明, 木崎昌弘, 片山直之, 土橋史明, 薄井紀子, 桐戸敬太.
    • Organizer
      第79回日本血液学会学術集会
    • Related Report
      2017 Annual Research Report
  • [Presentation] 変異型 CALR タンパク質の発現を制御するメカニズム.2017

    • Author(s)
      木原慶彦, 荒木真理人, 楊印杰, 今井美沙, 増渕菜弥, 水上喜久, 弘中由美, 竹井拓, 枝廣陽子, 大坂顯通, 小松則夫.
    • Organizer
      第79回日本血液学会学術集会
    • Related Report
      2017 Annual Research Report
  • [Presentation] BCR-JAK2 陽性骨髄増殖性腫瘍.2017

    • Author(s)
      筒井深雪, 後藤明彦, 森下総司, 荒木真理人, 福田泰隆, 新田英昭, 安藤純, 小松則夫.
    • Organizer
      第79回日本血液学会学術集会
    • Related Report
      2017 Annual Research Report
  • [Presentation] カルレチキュリン変異を有する血球前駆細胞は巨核球への分化偏向性を有する.2017

    • Author(s)
      竹井拓, 眞野修一, 増渕菜弥, 水上喜久, 今井美沙, 森下総司, 枝廣陽子, 弘中由美, 橳島麻衣, 常田聡, 遠藤大, 中村壮, 江藤浩之, 大坂顯通, 荒木真理人, 小松則夫.
    • Organizer
      2017年度生命科学系学会合同年次大会
    • Related Report
      2017 Annual Research Report
  • [Presentation] 変異型 CALR による巨核球分化偏向性は GATA2 の発現亢進と相関している.2017

    • Author(s)
      竹井拓, 眞野修一, 増渕菜弥, 水上喜久, 今井美沙, 森下総司, 枝廣陽子, 弘中由美, 橳島麻衣, 遠藤大, 中村壮, 江藤浩之, 大坂顯通, 荒木真理人, 小松則夫.
    • Organizer
      第79回日本血液学会学術総会
    • Related Report
      2017 Annual Research Report
  • [Presentation] iPS 細胞由来若返りCTL 治療のためのCD8b の役割.2017

    • Author(s)
      崎山祐未, 安藤美樹, 村越勇人, 安藤純, 大坂顯通, 小松則夫, 滝口雅文, 中内啓光.
    • Organizer
      第79回日本血液学会学術集会
    • Related Report
      2017 Annual Research Report
  • [Presentation] マウス胎仔における造血幹細胞依存性および非依存性の血球系譜の発生起源.2017

    • Author(s)
      横溝智雅, 渡邊直紀, 森誠一, 髙久智生, 大里元美, 小松則夫.
    • Organizer
      第79回日本血液学会学術集会
    • Related Report
      2017 Annual Research Report
  • [Presentation] Engagement of mutant calreticulin and MPL in a cellular compartment is required for MPL activation.2017

    • Author(s)
      Masubuchi N, Araki M, Hayashi E, Yang Y, Imai M, Mizukami Y, Hironaka Y, Takei H, Morishita S, Kihara Y, Edahiro Y, Ohsaka A, Komatsu N.
    • Organizer
      第79回日本血液学会学術集会
    • Related Report
      2017 Annual Research Report
  • [Presentation] 変異型CALRの細胞内コンパートメントへの局在がトロンボポエチン受容体の活性化に必要である.2017

    • Author(s)
      Araki M, Komatsu N.
    • Organizer
      第76回日本癌学会学術総会
    • Related Report
      2017 Annual Research Report
  • [Book] 血液専門医テキスト 改定第3版2019

    • Author(s)
      小松則夫.
    • Total Pages
      660
    • Publisher
      南江堂
    • Related Report
      2019 Annual Research Report
  • [Book] 未来型血液治療学2019

    • Author(s)
      小松則夫.
    • Total Pages
      254
    • Publisher
      中外医学社
    • Related Report
      2019 Annual Research Report
  • [Book] WHO分類改定第4版による白血病・リンパ系腫瘍の病態学2019

    • Author(s)
      木崎昌弘、田丸淳一、朝長万左男、小松則夫、吉岡智子,高橋直人,枝廣陽子,幣光太郎,下田和哉,水木満佐央,金倉譲,宮本敏浩,桐戸敬太,宮崎泰司,長谷川大輔,真部淳,南谷泰仁,麻生範雄,清井仁,佐々木伸也
    • Total Pages
      527
    • Publisher
      中外医学社
    • Related Report
      2018 Annual Research Report
  • [Book] WHO血液腫瘍分類 WHO分類2017をうまく活用するために2018

    • Author(s)
      直江知樹、小松則夫、宮崎泰司、中村栄男、飯田真介、大島孝一、木下朝博、吉野正
    • Total Pages
      463
    • Publisher
      医薬ジャーナル社
    • Related Report
      2018 Annual Research Report
  • [Book] インターフェロンの復活.2017

    • Author(s)
      小松則夫
    • Total Pages
      8
    • Publisher
      最新医学社
    • Related Report
      2017 Annual Research Report
  • [Book] 骨髄線維症(MF) ~分子病態の解明から新規治療薬の開発まで~ 序 ~骨髄線維症の現状と展望~2017

    • Author(s)
      小松則夫.
    • Total Pages
      5
    • Publisher
      医薬ジャーナル社
    • Related Report
      2017 Annual Research Report
  • [Book] これからの骨髄増殖性腫瘍の基礎研究と臨床のゴール.2017

    • Author(s)
      小松則夫, 桐戸敬太, 荒木真理人
    • Total Pages
      14
    • Publisher
      最新医学社
    • Related Report
      2017 Annual Research Report
  • [Book] 真性赤血球増加症 専門家による 私の治療.2017

    • Author(s)
      小松則夫.
    • Total Pages
      2
    • Publisher
      日本医事新報社
    • Related Report
      2017 Annual Research Report
  • [Book] 本態性血小板血症 専門家による 私の治療.2017

    • Author(s)
      小松則夫.
    • Total Pages
      2
    • Publisher
      日本医事新報社
    • Related Report
      2017 Annual Research Report
  • [Patent(Industrial Property Rights)] 骨髄増殖性腫瘍の診断2018

    • Inventor(s)
      森下総司, 小松則夫, 他
    • Industrial Property Rights Holder
      森下総司, 小松則夫, 他
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2018-078074
    • Filing Date
      2018
    • Related Report
      2018 Annual Research Report

URL: 

Published: 2017-04-28   Modified: 2021-02-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi